Investors in Biopharma

Pureos Bioventures is a venture capital fund, which invests exclusively in private innovative drug development companies, with a special emphasis on the next generation of biological drugs and drug formats. The fund’s portfolio companies are built on scientific excellence to develop therapies across a broad indication spectrum including oncology, immunology, ophthalmology, rare diseases, and neuroscience. Pureos has built a team with deep investment, operating and clinical expertise, that strives to impact patients’ lives by advancing innovative treatments for devastating diseases.

Deep Science Ventures (DSV) is a pioneering venture studio and fund that specializes in the systematic development and investment of science-driven companies. With a unique approach, DSV optimizes the process of turning cutting-edge scientific discoveries into successful commercial ventures. By bridging the gap between academia and entrepreneurship, DSV nurtures interdisciplinary teams to solve complex challenges and create transformative technologies. Through strategic investment and hands-on support, DSV accelerates the growth of startups at the intersection of science, technology, and business, shaping the future of innovation across diverse industries.

Accelerate@Babraham is the incubation programme of the Babraham Research Campus. One of the best places in Europe to start-up and scale-up a life science business. The Babraham Research Campus is considered to be the UK’s leading campus to support early-stage bioscience enterprise and is distinct in its co-location of bioscience companies with the Babraham Institute, a world-renowned research organisation.

NLC is the European healthtech venture builder, bringing science-based healthtech inventions to life. NLC Health Ventures - is dedicated to advancing health, making it accessible for everyone. By using entrepreneurship at scale, our unique NLC approach allows us to find inventions, and create and support ventures that have the potential to reach the patient. Led by winning teams, together with a dedicated network and driven by data and learnings.

Medicxi is a leading investment firm specializing in the life sciences sector. They are dedicated to supporting innovation and advancement in biotechnology, pharmaceuticals, and healthcare. Medicxi collaborates with pioneering entrepreneurs and talented management teams to accelerate the development of breakthrough therapies, medical technologies, and healthcare solutions. With a strategic focus on early and late-stage investments, Medicxi aims to address significant medical challenges and improve patient outcomes globally. Their team combines deep scientific and investment expertise to identify promising opportunities and provide critical support throughout the growth phases of portfolio companies.

We support early-stage biotech and longevity-focused founders that are changing the world. We help these companies gain industrial momentum, raise capital, and shape the future of biotech. Our approach is based on growing the whole ecosystem. We fund companies in complementary industrial sectors, empowering us to build a broad community of biotech innovators that can exchange their expertise and build on each other's successes.

Fountain Healthcare Partners is a life science venture capital firm based in Dublin Ireland with an office in New York. Fountain currently manages over €300M and is actively investing its third fund raised in 2019. The team at Fountain originally worked within the corporate VC group at Elan Corporation and raised its first independent fund in 2008. Fountain invests in drugs, devices and diagnostics with a focus on companies developing innovative products that address unmet medical needs and deliver significant pharmacoeconomic benefits.

They are a team of HealthTech entrepreneurs turned VC professionals who have founded laboratory groups, software companies, and tech companies. Now, they are looking to guide the next generation of HealthTech ventures.

Bioqube Ventures is a specialist life sciences investment firm based in Europe with a global footprint. They source, finance, and develop innovative therapeutic assets and technologies. They leverage their venture creation experience to translate and de-risk scientific innovation, advancing their investment portfolio and maximizing value for investors.